FDA Approvals
Hims 'able to move extremely quickly' if FDA greenlights six wellness peptides, CEO says
Endpoints News
Aug 11, 2026
FDA News
Hims & Hers is laying the groundwork to offer access to six banned consumer wellness peptides, should the FDA lift restrictions that prevent compounding pharmacies from making them. During its second-quarter earnings ...
Discussion
Sign in to join the discussion. Comments loading…